BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
7 hedge funds and large institutions have $8.31K invested in BriaCell Therapeutics Corp Warrant in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
180% more capital invested
Capital invested by funds: $2.97K → $8.31K (+$5.34K)
133% more funds holding
Funds holding: 3 → 7 (+4)
3.27% more ownership
Funds ownership: 2.99% → 6.27% (+3.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.35K |
| 2 |
VF
Virtu Financial
New York
|
+$1.31K |
| 3 |
HF
HRT Financial
New York
|
+$1.04K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$11 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$575 |
BCTXW Hedge Fund Activity: Q4 2025 in Review
7 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q4 2025, worth a combined $8.31K — up 180% from $2.97K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BCTXW positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.35K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $575 sold.
- 7 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q4 2025, up from 3 in Q3 2025.
- Funds reported $8.31K of BriaCell Therapeutics Corp Warrant stock for Q4 2025, up 180% quarter-over-quarter.
- 5 funds opened new BriaCell Therapeutics Corp Warrant positions in Q4 2025 and 1 closed out, a net change of +4 holders.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q4 2025 was Susquehanna International Group, an estimated $3.35K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q4 2025 was Two Sigma Securities, an estimated $575 sold.
Based on aggregated 13F filings for Q4 2025.